|
STAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.551710E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66815999999015E-05 |
| Normal-vs-Stage2 |
5.984000E-01 |
| Normal-vs-Stage3 |
7.504300E-03 |
| Normal-vs-Stage4 |
1.269520E-02 |
| Stage1-vs-Stage2 |
3.54520000001024E-06 |
| Stage1-vs-Stage3 |
1.028020E-01 |
| Stage1-vs-Stage4 |
6.446200E-01 |
| Stage2-vs-Stage3 |
4.819600E-03 |
| Stage2-vs-Stage4 |
5.381900E-03 |
| Stage3-vs-Stage4 |
5.257600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.90180000000573E-05 |
| Normal-vs-AfricanAmerican |
5.591600E-02 |
| Normal-vs-Asian |
5.057400E-03 |
| Caucasian-vs-AfricanAmerican |
8.381200E-01 |
| Caucasian-vs-Asian |
5.763400E-01 |
| AfricanAmerican-vs-Asian |
8.713400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.831910E-02 |
| Normal-vs-Female |
6.40960000000135E-05 |
| Male-vs-Female |
1.951180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.11730000002175E-06 |
| Normal-vs-Age(41-60Yrs) |
4.180600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.442360E-01 |
| Normal-vs-Age(81-100Yrs) |
7.138200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.024000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.895370E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.840270E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.459800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.035600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.296000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.594200E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
1.052040E-01 |
| Classical-VS-Normal |
2.15060000030576E-07 |
| Tall-VS-Follicular |
7.13810122121572E-11 |
| Tall-VS-Other |
2.482200E-02 |
| Tall-VS-Normal |
1.956910E-04 |
| Follicular-VS-Other |
2.803000E-01 |
| Follicular-VS-Normal |
9.978400E-03 |
| Other-VS-Normal |
8.538000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.704390E-02 |
| Normal-vs-N1 |
5.998800E-03 |
| N0-vs-N1 |
3.052800E-01 |
|
|
